San Diego-dependent Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug current market in February right after revealing promising data from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in Marc